<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02754778</url>
  </required_header>
  <id_info>
    <org_study_id>RedCarRisk-Study</org_study_id>
    <nct_id>NCT02754778</nct_id>
  </id_info>
  <brief_title>Influence of Conditional Workout Postpartum on Arterial Stiffness Among Women With Status After Preeclampsia, Superimposed Preeclampsia or HELLP-syndrome</brief_title>
  <acronym>RedCarRisk</acronym>
  <official_title>Evaluation of Practicability in Survey and Test Procedures and of Successful Implementation of Complex Interventions - Feasibility Analysis Based on a Pilot Study: Influence of Conditional Workout Postpartum on Arterial Stiffness Among Women With Status After Preeclampsia, Superimposed Preeclampsia or HELLP-syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Martin-Luther-Universität Halle-Wittenberg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Martin-Luther-Universität Halle-Wittenberg</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of practicability in survey and test procedures and of successful implementation
      of complex interventions - feasibility analysis based on a pilot study: Influence of
      conditional workout postpartum on arterial stiffness among women with status after
      preeclampsia, superimposed preeclampsia or HELLP-syndrome
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cardiovascular disease is the main cause of death among women in Europe and in the USA. Its
      costs amount annually more than 196 billions Euro in Europe. The federal state of
      Saxony-Anhalt occupies leading position in mortality in myocardial infarction and coronary
      heart disease in Germany. Up to 8 percent of all pregnant women develop a severe
      pregnancy-associated hypertension, like preeclampsia, superimposed preeclampsia or
      HELLP-syndrome. These women have an increased lifetime risk for cardio- and cerebrovascular
      diseases.

      The consecutive increasing arterial stiffness because of endothelial dysfunction is a
      determining factor in etiology of pregnancy-associated hypertension and results in increased
      cardiovascular risk. Aortal pulse wave velocity is used as Goldstandard for measuring
      arterial stiffness.

      Pregnant women suffering from a severe pregnancy-associated hypertension present higher
      levels in arterial stiffness measured by pulse wave velocity than healthy pregnant women.
      Pathological changes of the vascular systems persistent from 6 month until 10 years after
      delivery and give an explanatory approach for an increased cardiovascular longterm risk at
      these patients. Numerous medical associations like American Heart Association aim at reducing
      especially cardiovascular longterm risk in women with status after preeclampsia, superimposed
      preeclampsia or HELLP syndrome.

      Pregnancy-independent studies in patients with coronary heart disease and analysis in women
      with metabolic syndrome show a reduction of arterial stiffness by regular conditional
      workout.

      Scientific problem of this pilot study: If a reduction in arterial stiffness in women from a
      risk group - during a 6-month-ongoing intensive regular conditional workout within a
      midwife-supported teamwork and under inclusion of dietary interventions - achieved?
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">April 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>reduced aortic pulse wave velocity by 1m/s</measure>
    <time_frame>six month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>no arterial hypertension defined as blood pressure ≤140mmHg / 80mmHg without antihypertensic medication</measure>
    <time_frame>13 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Preeclampsia</condition>
  <condition>Superimposed Preeclampsia</condition>
  <condition>HELLP Syndrome</condition>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>no intervention, regular family life</description>
  </arm_group>
  <arm_group>
    <arm_group_label>intervention group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>6 month of regular conditional workout 1-3 times a week</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>conditional workout</intervention_name>
    <description>6 month of regular conditional workout 1-3 times a weak</description>
    <arm_group_label>intervention group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnosis of preeclampsia, superimposed gestosis or HELLP syndrome

          -  capacity for content

        Exclusion Criteria:

          -  eclamptic stroke

          -  New York Heart Association &gt; Stadium II

          -  severe neurological or orthopedic disabilities

          -  peripheral arterial occlusive disease

          -  severe disease of the newborn which leads to an intensive familial care
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marcus Riemer, Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maternity Clinic/Perinatal Treatment Center, Halle university hospital, Martin-Luther-Universität Halle-Wittenberg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gregor Seliger, Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maternity Clinic/Perinatal Treatment Center, Halle university hospital, Martin-Luther-Universität Halle-Wittenberg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Riemer Marcus, Dr. med.</last_name>
    <email>marcus.riemer@outlook.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gregor Seliger, Dr. med.</last_name>
    <phone>+49 345 557 3921</phone>
    <email>gregor.seliger@uk-halle.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Maternity Clinic/Perinatal Treatment Center, Halle university hospital, Martin-Luther-Universität Halle-Wittenberg</name>
      <address>
        <city>Halle (Saale)</city>
        <state>Sachsen Anhalt</state>
        <zip>06120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marcus Riemer, Dr. med.</last_name>
      <email>marcus.riemer@outlook.com</email>
    </contact>
    <contact_backup>
      <last_name>Gregor Seliger, Dr. med.</last_name>
      <phone>+49 345 557 3921</phone>
      <email>gregor.seliger@uk-halle.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>St. Elisabeth and St. Barbara Hospital / Women's clinic</name>
      <address>
        <city>Halle (Saale)</city>
        <state>Saint</state>
        <zip>06110</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marcus Riemer, MD</last_name>
      <phone>+4934521330</phone>
      <email>m.riemer@krankenhaus-halle-saale.de</email>
    </contact>
    <contact_backup>
      <last_name>Heike Erler, MD</last_name>
      <phone>+493452134341</phone>
      <email>fug@krankenhaus-halle-saale.de</email>
    </contact_backup>
    <investigator>
      <last_name>Sven Seeger, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 22, 2016</study_first_submitted>
  <study_first_submitted_qc>April 25, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 28, 2016</study_first_posted>
  <last_update_submitted>March 10, 2018</last_update_submitted>
  <last_update_submitted_qc>March 10, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Martin-Luther-Universität Halle-Wittenberg</investigator_affiliation>
    <investigator_full_name>Gregor Seliger</investigator_full_name>
    <investigator_title>Dr. med. Gregor Seliger</investigator_title>
  </responsible_party>
  <keyword>arterial stiffness</keyword>
  <keyword>preeclampsia</keyword>
  <keyword>HELLP-syndrome</keyword>
  <keyword>pulse wave velocity</keyword>
  <keyword>advanced glycation endproducts</keyword>
  <keyword>skin autofluorescence</keyword>
  <keyword>conditional workout</keyword>
  <keyword>postpartum</keyword>
  <keyword>cardiovascular risk</keyword>
  <keyword>pregnancy</keyword>
  <keyword>vicorder</keyword>
  <keyword>age reader</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Pre-Eclampsia</mesh_term>
    <mesh_term>HELLP Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

